Agmatine inhibits morphine-induced memory impairment in the mouse step-down inhibitory avoidance task

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 2, 2010, Pages 256-261

  Lu, Wei ^a   Dong, Hua Jin ^a   Gong, Zheng hua ^a   Su, Rui Bin ^a   Li, Jin ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Agmatine; Idazoxan; Imidazoline receptor; Memory; Morphine; Step down inhibitory avoidance test

Indexed keywords

AGMATINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG INHIBITION; DRUG MECHANISM; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRAINING;

ADRENERGIC ALPHA-ANTAGONISTS; AGMATINE; ANALGESICS, OPIOID; ANIMALS; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; IDAZOXAN; IMIDAZOLINE RECEPTORS; MALE; MEMORY DISORDERS; MENTAL RECALL; MICE; MORPHINE;

MUS;

EID: 77957761382     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.08.007     Document Type: Article

References (51)

1. Aricioglu-Kartal F., Uzbay I.T. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome. Life Sci 1997, 61:1775-1781.
2. Aricioglu F., Ercil E., Dulger G. Agmatine inhibits naloxone induced contractions in morphine-dependent guinea pig ileum. Ann NY Acad Sci 2003, 1009:147-151.
3. Aricioglu F., Korcegez E., Bozkurt A. Effect of agmatine on acute and mononeuropathic pain. Ann NY Acad Sci 2003, 1009:106-115.
4. Aricioglu F., Means A., Regunathan S. Effect of agmatine on the development of morphine dependence in rats: potential role of cAMP system. Eur J Pharmacol 2004, 504:191-197.
5. Arteni N.S., Lavinsky D., Rodrigues A.L., et al. Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol Learn Mem 2002, 78:465-469.
6. Chang C.H., Wu H.T., Cheng K.C., et al. Increase of beta-endorphin secretion by agmatine is induced by activation of imidazoline I (2A) receptors in adrenal gland of rats. Neurosci Lett 2010, 468:297-299.
7. Fairbanks C.A., Schreiber K.L., Brewer K.L., et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci 2000, 97:10584-10589.
8. Fairbanks C.A., Wilcox G.L. Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther 1997, 282:1408-1417.
9. Ferry B., McGaugh J.L. Involvement of basolateral amygdala alpha2-adrenoceptors in modulating consolidation of inhibitory avoidance memory. Learn Mem 2008, 15:238-243.
10. Flood J.F., Baker M.L., Davis J.L. Modulation of memory processing by glutamic acid receptor agonists and antagonists. Bain Res. 1990, 521:197-202.
11. Galea E., Regunathan S., Eliopoulos V., et al. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996, 316:247-249.
12. Introini I.B., McGaugh J.L., Baratti C.M. Pharmacological evidence of a central effect of naltrexone, morphine, and beta-endorphin and a peripheral effect of met- and leu-enkephalin on consolidation of an inhibitory response in mice. Behav Neural Biol 1985, 44:434-446.
13. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mselective opioid receptor agonist DAMGO in mice. J Pharmacol ExpTher 1994, 269:15-21.
14. Izquierdo I., Netto C.A. The brain beta-endorphin system and behavior: the modulation of consecutively and simultaneously processed memories. Behav Neural Biol 1985, 44:249-265.
15. Jafari M.R., Zarrindast M.R., Djahanguiri B. Influence of cholinergic system modulators on morphine state-dependent memory of passive avoidance in mice. Physiol Behav 2006, 88:146-151.
16. Jafari-Sabet M., Zarrindast M.R., Rezayat M., et al. The influence of NMDA receptor agonist and antagonist on morphine state-dependent memory of passive avoidance in mice. Life Sci 2005, 78:157-163.
17. Kalra S.P., Pearson E., Sahu A., et al. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci Lett 1995, 194:165-168.
18. Karadag H.C., Ulugol A., Tamer M., et al. Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats. Neurosci. Lett 2003, 339:88-90.
19. Kolesnikov Y., Jain S., Pasternak G.W. Modulation of opioid analgesia by agmatine. Eur J Pharmacol 1996, 296:17-22.
20. Li G., Regunathan S., Barrow C.J., et al. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994, 263:966-969.
21. Li J., Li X., Pei G., et al. Agmatine inhibited tolerance to and dependence on morphine in guinea pig ileum in vitro. Zhongguo Yao Li Xue Bao 1998, 19:564-568.
22. Ma M.X., Chen Y.M., He J., et al. Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice. Neuroscience 2007, 147:1059-1065.
23. Maurice T., Hiramatsu M., Itoh J., et al. Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 1994, 647:44-56.
24. McKay B.E., Lado W.E., Martin L.J., et al. Learning and memory in agmatine-treated rats. Pharmacol Biochem Behav 2002, 72:551-557.
25. Myhrer T., Paulsen R.E. Memory dysfunction following disruption of glutamergic systems in the temporal region of the rat: effects of agonistic amino acids. Bain Res 1992, 599:345-352.
26. Onal A., Delen Y., Ulker S., et al. Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum. Life Sci 2004, 73:413-428.
27. Parada J., Czuezwar S.J., Turski W.A. NBQX dose not affect learning and memory tasks in mice: a comparison with d-CPPene and ifenprodil. Brain Res Cogn Brain Res 1992, 1:67-71.
28. Piletz J.E., Chikkala D.N., Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther 1995, 272:581-587.
29. Pineda J., Ruiz-Ortega J.A., Martin-Ruiz R., et al. Agmatine does not have activity at α2-adrenoceptors which modulate the firing rate of locus coeruleus neurons: an electrophysiological study in rat. Neurosci Lett 1996, 219:103-106.
30. Pinthong D., Wright I.K., Hanmer C., et al. Agmatine recognizes α2-adrenoceptor binding sites but neither activates nor inhibits α2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1995, 351:10-16.
31. Pu L., Bao G.B., Xu N.J., et al. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 2002, 22:1914-1921.
32. Ragozzino M.E., Gold P.E. Task-dependent effects of intra-amygdala morphine injections: attenuation by intra-amygdala glucose injections. J Neurosci 1994, 14:7478-7485.
33. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol Sci 2000, 21:187-193.
34. Regunathan S., Feinstein D.L., Raasch W., et al. Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport. 1995, 6:1897-1900.
35. Regunathan S., Piletz J.E. Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci 2003, 1009:20-29.
36. Robbins T.W., Everitt B.J. Drug addiction: bad habits add up. Nature. 1999, 398:567-570.
37. Saha N., Datta H., Sharma P.L. Effects of morphine on memory: interactions with naloxone, propranolol and haloperidol. Pharmacology 1991, 42:10-14.
38. Stone W.S., Walser B., Gold S.D., et al. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav Neurosci 1991, 105:264-271.
39. Su R.B., Wang W.P., Lu X.Q., et al. Agmatine blocks acquisition and re-acquisition of intravenous morphine self-administration in rats. Pharmacol Biochem Behav 2009, 92(4):676-682.
40. Su R.B., Ren Y.H., Liu Y., et al. Effect of agmatine on morphine induced discrimination in rats. Eur J Pharmacol 2008, 593(1-3):62-67.
41. Vaccarino A.L., Olson G.A., Olson R.D., et al. Endogenous opiates. Peptides 1998, 20:1527-1574. 1999.
42. Valili A., Tayebi K., Jafari M.R., et al. Effect of ethanol on morphine state-dependent learning in the mouse: involvement of GABAergic, opioidergic and cholinergic systems. Alcohol Alcohol 2004, 39:427-432.
43. Walker D.L., McGlynn T., Grey C., et al. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists. Psychopharmacology (Berl). 1991, 105:57-62.
44. Ward L., Manson S.E., Abraham W.C. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats. Pharmacol Biochem Behav. 1990, 35:785-790.
45. Wei X.L., Su R.B., Yuan B.L., et al. Inhibition by agmatine on morphine-induced conditioned place preference in rats. Eur J Pharmacol 2005, 515(1-3):99-106.
46. Yamada K., Noda Y., Hasegawa T., et al. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J Pharmacol Exp Ther 1996, 276:460-466.
47. Yamada K., Hiramatsu M., Noda Y., et al. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience 1996, 74:365-374.
48. Yang X.C., Reis D.J. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 1999, 288.
49. Yesilyurt O., Uzbay I.T. Agmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology 2001, 25:98-103.
50. Zarrindast M.R., Fazli-Tabaei S., Ahmadi S., et al. Effect of lithium on morphine state-dependent memory of inhibitory avoidance in mice. Physiol Behav 2006, 87:409-415.
51. Zheng J.Q., Weng X.C., Gai X.D., et al. Mechanism underlying blockade of voltage-gated calcium channels by agmatine in cultured rat hippocampal neurons. Acta Pharmacol Sin 2004, 25:281-285.